Akebia Therapeutics to Present at the 38th Annual J.P. Morgan Healthcare Conference

CAMBRIDGE, Mass.--()--Akebia Therapeutics, Inc. (Nasdaq: AKBA), a biopharmaceutical company focused on the development and commercialization of therapeutics for people living with kidney disease, today announced that its President and Chief Executive Officer, John P. Butler, will present at the 38th Annual J.P. Morgan Healthcare Conference on Wednesday, January 15, 2020 at 9:30 a.m. PT in San Francisco.

A live webcast and replay of Akebia’s presentation and associated Q&A will be available on the Company’s website at www.akebia.com.

About Akebia Therapeutics

Akebia Therapeutics, Inc. is a fully integrated biopharmaceutical company focused on the development and commercialization of therapeutics for people living with kidney disease. The Company was founded in 2007 and is headquartered in Cambridge, Massachusetts. For more information, please visit our website at www.akebia.com, which does not form a part of this release.

Contacts

Kristen K. Sheppard, Esq.
ir@akebia.com

Contacts

Kristen K. Sheppard, Esq.
ir@akebia.com